Table 1.
Table of demographics
| Number of occasions (n = 436) | |
|---|---|
| Reported dose (mg); Median (IQR) | 1500 (600–3000) |
| Phenotypic characteristics | |
| Age (years); Median (IQR) | 37 (25–43) |
| Gender Females, n (%) | 330 (77.5) |
| Decontamination | |
| No decontamination, n (%) | 259 (59.4) |
| SDAC, n (%) | 102 (23.4) |
| Whole bowel irrigation (WBI), n (%) | 36 (8.26) |
| SDAC + WBI, n (%) | 39 (8.94) |
| Formulation | |
| Standard release (IR), n (%) | 216 (50.7) |
| Extended release (SR), n (%) | 220 (51.6)* |
| Seizures, n (%) | 24 (5.63) |
| Time of seizures (h) | 6.17 (2.92–12) |
The total number of patients in the study was 319
18 patients took both standard and extended release.